Now given the trade name Ojjaara, GSK's once-daily oral JAK1/JAK2 and activin A receptor type 1 (ACVR1) inhibitor can be given as an alternative to other JAK inhibitors in the first-line setting ...

saw new competition arrive on the market last month with the FDA's approval of GSK’s Ojjaara (momelotinib). Jakafi accounted for $682 million of Incyte’s second-quarter sales of $827 million ...

The top 10 US bank logos demonstrate how thoughtful and strategic design can communicate values, build trust, and leave an impression. A company's logo serves as the face of its brand, encapsulating ...

Fedratinib [Inrebic] has a little less activity against JAK1. Momelotinib [Ojjaara] inhibits both pathways but also inhibits ACVR1. And pacritinib [Vonjo] does not have an effect on JAK1 but has an ...

This unique world exists on board the ship Logos Hope, my home for the next 2 years. I have been living on board for over a month and the life on Logos Hope is both exciting and challenging at the ...

Explore how the Bank of America logo balances tradition with innovation through its distinctive flag design and strategic deployment across physical and digital touchpoints.